"We would encourage you to visit www.coronavirus.gov for the latest information and guidance related to COVID-19"


Stanley A. Plotkin, Ph.D.

Consultant and Emeritus Professor of the University of Pennsylvania, Vaxconsult, LLP

Presentation Title

Andrew J Pollard, FMedSci

Ashall Professor of Paediatric Infection and Immunity and Director of Oxford Vaccine Group

Presentation Title

Walter Straus, MD, MPH, FACP

Vice-President, Clinical Safety, Moderna

Jay A. Berzofsky, MD.,Ph.D

Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute

Presentation Title

Ofer Levy, MD, PhD

Staff Physician & Principal Investigator, Director, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital Professor, Harvard Medical School

Hanneke Schuitemaker, PhD

VP, Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines and Prevention B.V.

Presentation Title

Karin Bok, MS, PhD

Acting Deputy Director, Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Presentation Title

Swati Gupta, DrPH, MPH

VP, Emerging Infectious Diseases and Epidemiology, IAVI

Presentation Title

Dan Barouch, M.D., Ph.D.

William Bosworth Castle Professor of Medicine, Harvard Medical School, Ragon Institute of MGH, MIT, and Harvard, Director, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center

Presentation Title

David B. Weiner, Ph.D.

Executive Vice President, The Wistar Institute, Director, Vaccine & Immunotherapy Center

Kate Broderick, Ph.D.

Chief Innovation Officer, Maravai LifeSciences

Presentation Title

Francesco Berlanda Scorza, Ph.D.

VP, Global Health R&D Vaccines Head and GVGH Institute Director, GSK Vaccines Institute for Global Health

Presentation Title

Richard B. Kennedy, Ph.D.

Professor of Medicine, Co-Director, Mayo Clinic Vaccine Research Group

Presentation Title


Professor of Global Health and Vaccinology at the University of Oxford and the University of Siena

Presentation Title

Tom Henley, PhD

Chief Scientific Officer, Intima Bioscience 

Presentation Title

Marco Pravetoni, Ph.D.

Professor of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Director, Center for Medication Development for Substance Use Disorders and Overdose

Barbara A Jones, Ph.D.

IBM Quantum, IBM Research Almaden

Alexander Bukreyev, Ph.D.

Professor, Co-Principal Investigator Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus, Departments of Pathology and Microbiology & Immunology, Galveston National Laboratory, University of Texas Medical Branch

Farshad Guirakhoo, Ph.D.

Chief Scientific Officer, ExpreS2ion Biotechnologies

Presentation Title

Stephen L. Hoffman, M.D.

Chief Executive and Scientific Officer, Sanaria Inc.

Rama Rao Amara, Ph.D.

Charles Howard Candler Professor, Department of Microbiology and Immunology, Associate Director, Vaccine Development, Emory Vaccine Center, Co-Director, Developmental Core, Emory CFAR, Emory National Primate Research Center, Emory University

Robert O. Dillman, M.D.

Chief Medical Officer, AIVITA Biomedical, Inc., Clinical Professor of Medicine, UC Irvine

Presentation Title

Magdalena Tary-Lehmann, M.D., Ph.D.

Chief Scientific Officer, Cellular Technology Limited, Adjunct Associate Professor of Pathology, Case Western Reserve University

John Shon, MD, MS

Chief Technology Officer, Serimmune

Shahin Gharakhanian, MD, DPH

Chief Medical Officer & SAB Chair, DECOY Therapeutics, Cambridge MA, USA

Biao He, Ph.D.

President & CEO, CyanVac LLC

Christopher Rudd, PhD, DSc, FRSC

Professeur, Faculte de Medicine, Dept de microbiologie, infectiologie et immunologie, Director-Cell Signaling and Immunotherapy Section, Centre de Recherche Hopital Maisonneuve-Rosemont

Sriram Sathy, Ph.D.

Chief Scientific Officer, Codiak

Jonathan Lovell, Ph.D.

SUNY Empire Innovation Associate Professor, Department of Biomedical Engineering, Jacobs School of Medicine & Biomedical Sciences, University of Buffalo

Mark Connors, M.D.

Chief, HIV-Specific Immunity Section, NIAID/LIR

Presentation Title

Jorge C. Blanco, Ph.D.

President and Scientific Director, Sigmovir Biosystems Inc.

Trudy Morrison, Ph.D.

University of Massachusetts Chan Medical School

Vaithilingaraja Arumugaswami, Ph.D.

Adjunct Associate Professor Molecular and Medical Pharmacology, University of California Los Angeles

Pi-Hui Liang, Ph.D.

Founder, ImmunAdd

Janet K. Yamamoto, Ph.D.

Professor and Director of VAB BSL-3 V3-213D Laboratory & LCIV-CA, Dept of Comparative, Diagnostic, and Population Medicine, College of Veterinary Medicine, University of Florida


Professor & Vice Chair of Research, Department of Pharmacology & Experimental Neuroscience, The University of Nebraska Medical Center

Tian (Tina) Wang, Ph.D.

Professor, Departments of Microbiology & Immunology and Pathology, Director, NIAID T35 Infectious Diseases & Inflammatory Disorder Training Program, Member, Sealy Institute for Vaccine Sciences

Daniel Kulp, Ph.D.

Associate Professor, Vaccine & Immunotherapy Center, The Wistar Institute

Marcus Buggert, Ph.D.

Assistant Professor, Karolinska Institutet

Martha A. Alexander-Miller, Ph.D.

Dolores G. Evans Ph.D. Chair in Microbiology and Immunology, Professor and Chair, Dept. of Microbiology and Immunology, Director Center for Vaccines at the Extremes of Aging, Wake Forest School of Medicine

Sukrit Srivastava, Ph.D.

Center for Structural Systems Biology (CSSB) & Indian Foundation for Fundamental Research Trust

Gongyi Zhang, Ph.D.

Professor, Department of Immunology and Genomic Medicine, National Jewish Health, Founder, NB Life Laboratory, LLC, Colorado, USA

Yuri L. Lyubchenko, PhD, DSc, Professor

Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center

Presentation Title

Andrew Lees, Ph.D.

CEO/CSO, Fina Biosolutions

Presentation Title

Gary R. Matyas, Ph.D.

Chief, Adjuvants and Formulation Section, Laboratory of Adjuvant and Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research

Presentation Title

Oretta Finco, Ph.D.

Head of B Cell Center of Excellence (CoE) and Head of IT-Immunology, GSK (Bacterial Vaccines Unit)

Gavin Painter, Ph.D.

Victoria University Wellington

Presentation Title

Niraj H. Tolia, Ph.D.

Senior Investigator, Chief, Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, Division of Intramural Research, NIAID/NIH

Jörg Hermann Fritz, Ph.D

Director, McGill Research Center on Complex Traits (MRCCT), Associate Professor, McGill University

Sebastian L Johnston, MBBS Ph.D

Professor of Respiratory Medicine & Allergy, Head, Airway Disease, National Heart and Lung Institute, Imperial College London

Presentation Title

Edward T. Ryan, M.D., DTM&H

Director, Global Infectious Diseases; Division of Infectious Diseases, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School, Professor of Immunology & Infectious Diseases, Harvard T.H. Chan School of Public Health

Presentation Title

Roberto Adamo, Ph.D

Vaccine Development Leader, GSK

Presentation Title

De-chu Christopher Tang, Ph.D

CEO; VaxDome Inc., Commercialization Program, University of North Texas Health Science Center

Presentation Title

Jolieke G. van Oosterwijk, PhD, MSc

Chief Scientific Officer, US BIOLOGIC

Wei Zou, PhD

Senior Research Officer, Human Health Therapeutic Research Center, National Research Council of Canada

Presentation Title

Mehul S. Suthar, PhD

Associate Professor, Department of Pediatrics-Infectious Disease, Emory University School of Medicine

Xingmin Sun, PhD

Associate Professor, Department of Molecular Medicine, College of Medicine at the University of South Florida (USF).

Presentation Title

Mark A. Emalfarb, PhD

CEO, Dyadic International, Inc.

Presentation Title

Ruben Rizzi, MD

Vice President of Global Regulatory Affairs, BioNTech

Presentation Title

Robert van der Put, MSc

Director Business Development, Scientist Process Development Conjugate Vaccines, Intravacc.nl

Presentation Title

Thomas Tillett

Cofounder and CEO, MBF Therapeutics

Jerald Sadoff, PhD

Senior Advisor Development, ID&V Therapeutic Area for Janssen R&D US, Johnson & Johnson

Nash Rochman, PhD

Principal Investigator, National Institutes of Health

Ulo Palm, MD, Ph.D., MBA

Chief Medical Office, Vaxxinity

M. Javad Aman, Ph.D.

President and CEO, AbVacc, Inc

Alexander Rumyantsev, MD, Ph.D., MBA

Therapeutic Area Head, Infectious Diseases, Vaxxinity

Byron Brook, Ph.D.

Research Fellow, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Harvard Institutes of Medicine

Stephen J. Elledge, Ph.D.

Department of Genetics, Harvard Medical School

Ling CHEN, M.D.,Ph.D.

Guangzhou Laboratory, Guangzhou, China

Presentation Title

Afzal A. Siddiqui, M.Phil., Ph.D.

Grover E. Murray Professor, Chair, Immunology & Molecular Microbiology, Texas Tech University Health Sciences Center

Presentation Title

Peter Nara, Ph.D.

Co-Founders, Chief Scientific Officer, and President of Business Development for Keystone Bio Inc.

Hangwen Li, Ph.D.

Founder, Chairman, and CEO, Stemirna Therapeutics Co., Ltd.

Jessica McDonough, Ph.D.

Co-Founder, Attivare Tx

Presentation Title

Markus Mandler, Ph.D.

Founder and CEO, of Tridem Bioscience

Presentation Title

Mukesh Kumar, Ph.D.

Associate Professor, Department of Biology, Georgia State University

Presentation Title

Eric Andrew Appel, Ph.D.

Associate Professor and Director of Graduate Studies, Stanford University

Rachel A. Liberatore, Ph.D.

President & Chief Scientific Officer, RenBio, Inc

Presentation Title

Michael A Schotsaert, Ph.D.

Assistant Professor, Microbiology, Icahn School of Medicine at Mount Sinai

Presentation Title

Francesco Berti, Ph.D.

Senior Director, GSK Vaccines, Presentation Title: Recent advancements in the glycoconjugate vaccines field

Presentation Title

Sabine Hauck, Ph.D.

EVP Corporate Development, Leukocare AG

Presentation Title

Francesco Citiulo, Ph.D.

Senior Scientist, Research and Development skills in vaccinology, GSK

Presentation Title

Olivia Burn, Ph.D.

Post-doctoral Research Fellow, Malaghan Institute of Medical Research

Presentation Title

Kevin O. Saunders, Ph.D.

Director, Laboratory of Protein Expression, Duke Human Vaccine Institute, Associate Director, Duke Human Vaccine Institute, Duke University Medical Center

Giuseppe Stefanetti, PhD, MBA

Assistant Professor, Urbino University

Presentation Title

Alan Herbert, PhD, MBA

President and Founder, InsideOutBio.com

Presentation Title

Richard S. Kornbluth, MD, PhD

President & Chief Scientific Officer, Multimeric Biotherapeutics, Inc

Presentation Title

Yuri L. Lyubchenko, PhD, DSc, Professor

Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center

Jean D. Boyer, PhD

VP Preclinical R&D, IMUNON

Presentation Title

Ramesh Matur, PhD

Senior Vice President and Head, Vaccines R&D Division, Biological E Ltd

Presentation Title

Sumana Sundaramurthy

Technical Account Manager at Sino Biological

Presentation Title

Byron Brook, PhD

Research Fellow, Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital

Presentation Title

Lauren Charbon

Head of Product Marketing, BlueDot Global

Jian He (Jason)

CMC Head, WuXi Vaccines

Presentation Title

About Organizer

Scientia Meetings understand the importance of networking and collaboration. Conferences are not just about discussion, but to sharing knowledge and research work, new ideas, and a lot of opportunities. We are launching events in the country to create real networking with scientists and researchers from research institutes, companies, laboratories, and government agencies. We aim to have our events with only a moderate number of invited guests/delegates attending related to discipline and to create a platform to have conversations leading to opportunities according to their respective needs. Our aim is to provide a platform for research scholars, scientific leaders, decision-makers to come together and share their research findings with the other scientific professionals which helps to improve the sharing of knowledge and easy access to scientific information.

We provide a unique opportunity to share your innovative ideas, evaluate your research works, and promote collaborative work through its networking sessions for a brighter future.